A First-in-Human Phase I Trial of OX118 in Healthy Volunteers
NCT07020156
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Immune System
Interventions
DRUG:
OX118 or placebo
Sponsor
Oxion Biologics AB